RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Chicago, IL · Schaumburg, IL · Willowbrook, IL · +44 more sites
Clinical trials in Willowbrook, IL
14 recruiting studies have a site in or near Willowbrook, IL, Illinois.
Top conditions here
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 14 of 14 studies
RecruitingPhase 2NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Sponsor: Hoffmann-La Roche
Willowbrook, IL · +17 more sites
RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Chicago, IL · Willowbrook, IL · +61 more sites
RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Skokie, IL · Willowbrook, IL · +23 more sites
RecruitingPhase 3NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sponsor: Novartis Pharmaceuticals
Willowbrook, IL · +19 more sites
RecruitingPhase 2NCT07737743
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Sponsor: Novartis Pharmaceuticals
Chicago, IL · Willowbrook, IL · +7 more sites
RecruitingPhase 2NCT07276581
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Sponsor: AstraZeneca
Skokie, IL · Willowbrook, IL · +27 more sites
RecruitingPhase 2NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Sponsor: AbbVie
Chicago, IL · Libertyville, IL · Orland Park, IL · +46 more sites
RecruitingPhase 2NCT07321873
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Sponsor: Janssen Research & Development, LLC
Willowbrook, IL · +17 more sites
RecruitingPhase 3NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Willowbrook, IL · +30 more sites
RecruitingPhase 3NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Sponsor: Janssen Research & Development, LLC
Willowbrook, IL · +37 more sites
RecruitingPhase not listedNCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Sponsor: Bristol-Myers Squibb
Willowbrook, IL · +25 more sites
RecruitingPhase 2NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Sponsor: Artiva Biotherapeutics, Inc.
Willowbrook, IL · +30 more sites
RecruitingPhase 2NCT06865105
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Sponsor: AbbVie
Skokie, IL · Willowbrook, IL · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.